87 related articles for article (PubMed ID: 9372594)
1. Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide.
Volpini R; Camaioni E; Lupidi G; Vittori S; Cristalli G
Farmaco; 1997; 52(6-7):429-33. PubMed ID: 9372594
[TBL] [Abstract][Full Text] [Related]
2. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles.
Cristalli G; Eleuteri A; Volpini R; Vittori S; Camaioni E; Lupidi G
J Med Chem; 1994 Jan; 37(1):201-5. PubMed ID: 8289197
[TBL] [Abstract][Full Text] [Related]
3. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
[TBL] [Abstract][Full Text] [Related]
4. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.
Barankiewicz J; Danks AM; Abushanab E; Makings L; Wiemann T; Wallis RA; Pragnacharyulu PV; Fox A; Marangos PJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1230-8. PubMed ID: 9399998
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA].
Pragnacharyulu PV; Varkhedkar V; Curtis MA; Chang IF; Abushanab E
J Med Chem; 2000 Nov; 43(24):4694-700. PubMed ID: 11101360
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
[TBL] [Abstract][Full Text] [Related]
7. ADA2 isoform of adenosine deaminase from pleural fluid.
Andreasyan NA; Hairapetyan HL; Sargisova YG; Mardanyan SS
FEBS Lett; 2005 Jan; 579(3):643-7. PubMed ID: 15670822
[TBL] [Abstract][Full Text] [Related]
8. [Conformation of adenosine deaminase in complexes with inhibitors: application of selective quenching of fluorescence emission].
Vermishian IG; Sharoian SG; Antonian AA; Grigorian NA; Mardanian SS; Khoetsian AV; Markarian ShA
Biofizika; 2008; 53(2):213-21. PubMed ID: 18543763
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
[TBL] [Abstract][Full Text] [Related]
11. Effect of a chemical modification on the hydrated adenosine intermediate produced by adenosine deaminase and a model reaction for a potential mechanism of action of 5-aminoimidazole ribonucleotide carboxylase.
Groziak MP; Huan ZW; Ding H; Meng Z; Stevens WC; Robinson PD
J Med Chem; 1997 Oct; 40(21):3336-45. PubMed ID: 9341908
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Antonioli L; Fornai M; Colucci R; Ghisu N; Da Settimo F; Natale G; Kastsiuchenka O; Duranti E; Virdis A; Vassalle C; La Motta C; Mugnaini L; Breschi MC; Blandizzi C; Del Taca M
J Pharmacol Exp Ther; 2007 Aug; 322(2):435-42. PubMed ID: 17488880
[TBL] [Abstract][Full Text] [Related]
13. Novel, highly potent adenosine deaminase inhibitors containing the pyrazolo[3,4-d]pyrimidine ring system. Synthesis, structure-activity relationships, and molecular modeling studies.
Da Settimo F; Primofiore G; La Motta C; Taliani S; Simorini F; Marini AM; Mugnaini L; Lavecchia A; Novellino E; Tuscano D; Martini C
J Med Chem; 2005 Aug; 48(16):5162-74. PubMed ID: 16078836
[TBL] [Abstract][Full Text] [Related]
14. Screening solution-phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectrometry.
Zhao YZ; van Breemen RB; Nikolic D; Huang CR; Woodbury CP; Schilling A; Venton DL
J Med Chem; 1997 Dec; 40(25):4006-12. PubMed ID: 9406591
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
[TBL] [Abstract][Full Text] [Related]
16. Conformational change of adenosine deaminase during ligand-exchange in a crystal.
Kinoshita T; Tada T; Nakanishi I
Biochem Biophys Res Commun; 2008 Aug; 373(1):53-7. PubMed ID: 18549808
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine.
Vargeese C; Sarma MS; Pragnacharyulu PV; Abushanab E; Li SY; Stoeckler JD
J Med Chem; 1994 Oct; 37(22):3844-9. PubMed ID: 7966142
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of adenosine deaminase. Studies in combining high-affinity enzyme-binding structural units. erythro-1,6-Dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine and erythro-9-(2-hydroxy-3-nonyl)purine.
Woo PW; Baker DC
J Med Chem; 1982 May; 25(5):603-5. PubMed ID: 7086847
[TBL] [Abstract][Full Text] [Related]
19. Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.
Kandalkar SR; Ramaiah PA; Joshi M; Wavhal A; Waman Y; Raje AA; Tambe A; Ansari S; De S; Palle VP; Mookhtiar KA; Deshpande AM; Barawkar DA
Bioorg Med Chem; 2017 Oct; 25(20):5799-5819. PubMed ID: 28951094
[TBL] [Abstract][Full Text] [Related]
20. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]